The Exchange has sought clarification from Lasa Supergenerics Limited for the quarter ended 31-Dec-2025 with respect to Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. On basis of above the Company is required to clarify the following: -1. Financial results submitted is not as per format prescribed by SEBI. The response of the Company is awaited.
LASA · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
The National Stock Exchange (NSE) has asked Lasa Supergenerics Limited to clarify its financial results submitted for the quarter ended 31 December 2025. The exchange flagged that the results were not filed in the format prescribed by SEBI under Regulation 33 of the Listing Obligations and Disclosure Requirements (LODR) Regulations, 2015. Regulation 33 deals with the mandatory submission of quarterly and annual financial results by listed companies. The company has not yet responded to the exchange's query, and its clarification is awaited. This is a procedural compliance issue rather than a question about the underlying financial performance of the company. Investors will be watching for the company's response to ensure the matter is resolved promptly.
This is a minor compliance-related concern and does not directly impact the company's financials. However, repeated or unresolved clarifications may dent investor confidence in governance standards and could keep the stock under short-term scrutiny.